Diabetes, metabolic syndrome and obesity: targets and therapy 11726 Anson M, Zhao SS, Austin P, Ibarburu GH, Malik RA, Alam U (2023) SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
Get Directions
Tardif JC, Karwatowska-Prokopczuk E, Amour ES, et al
Reflecting this evolving understanding, various global expert groups, including a panel from eastern and southern Europe, are collectively calling for a paradigm shift away from traditional glucose-centric diabetes care and toward a more holistic approach that prioritizes obesity and cardiometabolic complications [46]
GLP-1 Studio Podcast The GLP-1 Collective is proud to recommend the GLP-1 Studio Podcast , a patient-centered show hosted by our founder, Amanda Bonello
A potent anti-inflammatory peptide, KPV is researched for supporting gut and skin health while helping to reduce systemic inflammation